Dawn Svoronos insider trades
Open-market stock purchases and sales by Dawn Svoronos, Unknown at Xenon Pharmaceuticals Inc, from SEC Form 4 filings since Jun 27, 2014.
Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -56%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jun 3, 2026 | XENE Xenon Pharmaceuticals Inc | Bought (not open market) | — |
| Jun 3, 2026 | XENE Xenon Pharmaceuticals Inc | Bought (not open market) | — |
| Jun 1, 2026 | XENE Xenon Pharmaceuticals Inc | Sold (not open market) | $75.6K |
| Jun 1, 2026 | XENE Xenon Pharmaceuticals Inc | Bought (not open market) | — |
| Dec 9, 2025 | ADVM Adverum Biotechnologies, Inc | Sold (not open market) | $77K |
| Dec 9, 2025 | ADVM Adverum Biotechnologies, Inc | Sold (not open market) | $24.2K |
| Dec 9, 2025 | ADVM Adverum Biotechnologies, Inc | Sold (not open market) | — |
| Dec 9, 2025 | ADVM Adverum Biotechnologies, Inc | Sold (not open market) | $62.4K |
| Dec 9, 2025 | ADVM Adverum Biotechnologies, Inc | Sold (not open market) | $577K |
Companies traded
- XENE Xenon Pharmaceuticals Inc: 1 buy, 1 sale, last Jun 3, 2026
- ADVM Adverum Biotechnologies, Inc: 2 buys, last Dec 9, 2025
- SLRN ACELYRIN, Inc: 1 buy, last May 21, 2025
- GBT Global Blood Therapeutics, Inc: 4 sales, last Oct 5, 2022
- PTCT PTC Therapeutics, Inc: 1 buy, 5 sales, last Jun 9, 2022
- ECYT Endocyte Inc: other filings, last Dec 21, 2018
- MDVN Medivation, Inc: 3 sales, last Sep 28, 2016